The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received reports of Emerade pens failing to activate. This means that in some cases, the needle is not released, and the injection of adrenaline is not delivered.

People in the UK who have been supplied with an Emerade pen are advised to read this issued alert for more information.